May 6, 2019
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Donald Field
| Re: | Twist Bioscience Corporation Acceleration Request |
Acceleration Request
| Requested Date: | May 8, 2019 | |||
| Requested Time: | 4:30 p.m. Eastern Time |
Ladies and Gentlemen:
Twist Bioscience Corporation (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-1 (FileNo. 333-231239), as amended, effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Company hereby authorizes Andrew D. Thorpe or Melissa V. Frayer, both of whom are attorneys with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration.
The Company requests that it be notified of such effectiveness by a telephone call to Mr. Thorpe at(415) 773-5970, or in his absence, Ms. Frayer at(415) 773-5402.
[Signature page follows]
| Sincerely, | ||
| TWIST BIOSCIENCE CORPORATION | ||
| By: | /s/ Mark Daniels | |
| Name: | Mark Daniels | |
| Title: | Chief Legal Officer, Secretary and Chief Ethics and Compliance Officer | |
| cc: | Emily Leproust, Twist Bioscience Corporation |
Andrew D. Thorpe, Orrick, Herrington & Sutcliffe, LLP
Melissa V. Frayer, Orrick, Herrington & Sutcliffe, LLP
Brian J. Cuneo, Latham & Watkins LLP